Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
Accessnewswire·2025-10-21 12:30

Core Insights - Tenon Medical, Inc. has received FDA 510(k) clearance for its SImmetry+ SI Joint Fusion System, enhancing its competitive advantage in treating sacro-pelvic disorders [1] Company Developments - The SImmetry+ System is designed for sacroiliac joint fusion, addressing conditions such as sacroiliac joint disruptions and degenerative sacroiliitis [1] - The company is initiating an alpha launch of the SImmetry+ with a select group of physician users to gather initial feedback for a broader launch [1] Product Features - SImmetry+ includes new 3D printed titanium implants, a robust joint decorticator, and a simple bone graft delivery system, providing physicians with treatment options based on established fusion principles [1]